Audrey B.
- Country
- France
- Department
- oncologie
Research Overview
- Phase III Randomized Trial of Maintenance Olaparib Versus Observation Post-Adjuvant Chemoradiation in p53abn Endometrial Carcinoma
- Evaluation of Chemotherapy Versus Endocrine Therapy as Second-Line Treatment in ER-Positive HER2-Negative Metastatic Breast Cancer Using Fluoroestradiol F-18
- Evaluation of 18F-Fluoroestradiol PET/CT Impact on Management of ER+ HER2- Metastatic Breast Cancer Relapsing Post-Hormone Therapy
Data & Insights
Has run more than one trial at 18 of 54 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in treating metastatic breast cancer with particular focus on cases characterized by estrogen receptor-positive (ER+) and HER2-negative expression patterns.
- Hormone Therapy Applications
- CDK4/6 Inhibitor Treatments
- Molecular Imaging Techniques
The research involves advanced diagnostic approaches using 18F-FES PET/CT imaging to guide therapeutic decisions.
Endometrial Cancer Studies
The investigator conducts research in high-risk endometrial cancer treatment, with particular attention to p53-abnormal variants and novel therapeutic approaches.
- Adjuvant Treatment Strategies
- Maintenance Therapy Protocols
- Post-surgical Treatment Optimization
Research includes evaluation of targeted maintenance therapies following standard chemoradiotherapy treatments.
Gynecologic Oncology
The investigator explores innovative treatments for carcinosarcomas affecting both endometrial and ovarian tissues, focusing on advanced or recurrent disease states.
- Combination Immunotherapy Approaches
- Novel Treatment Strategies
- Recurrent Disease Management
Research encompasses targeted therapeutic combinations for patients who have undergone prior chemotherapy treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.